Clinical Trials Browser

Prostatic Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Lymphoma, B-Cell, Hematologic Neoplasms

NCT05332054 2026-03-12

LTFS

Enrolling by invitation

150 enrolled

LymphoidOther hematologic neoplasmPlasma cell

Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma, Leukemia, Myeloid, Acute, Lymphoma, B-Cell, Hematologic Neoplasms

NCT00923442 2026-01-05

Biology Studies of Hematologic Cancers

Enrolling by invitation

550 enrolled

LymphoidMyeloidOther hematologic neoplasm

Hodgkin Disease, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04093570 2025-10-31

A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)

Phase 2 Enrolling by invitation

332 enrolled

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

NCT06788509 2025-10-10

A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring

Phase 1 Enrolling by invitation

80 enrolled

LymphoidMyeloidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute

NCT07014462 2025-10-06

DLIT-AML

Phase 1 Enrolling by invitation

20 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT06697327 2025-05-14

Daunorubicin + Cytarabine + Venetoclax in de Novo AML

Phase NA Enrolling by invitation

94 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT02646839 2025-05-04

KIR Favorable Mismatched Haplo Transplant and KIR Polymorphism in ALL/AML/MDS Allo-HCT Children

Phase 2 Enrolling by invitation

50 enrolled

LymphoidMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03507842 2025-03-17

A Prospective Randomized Comparison of HDAC Vs AD in the Induction Chemothrapy for AML.

Phase 3 Enrolling by invitation

380 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT05674539 2025-02-10

Reduced Intensity Conditioning Regimens for Acute Myeloid Leukemia and Myelodysplastic Syndrome

Phase 3 Enrolling by invitation

200 enrolled

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT05212103 2024-12-04

CANSI

Enrolling by invitation

30 enrolled

DermatologicOther hematologic neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma, Leukemia, Myeloid, Acute

NCT05983172 2023-08-14

Multi-omics Approach of Risk Stratification for Patients With de Novo Acute Myeloid Leukemia

Enrolling by invitation

1,500 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

Clinical Trials

PERSIST

LTFS

Biology Studies of Hematologic Cancers

A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)

A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring

DLIT-AML

Daunorubicin + Cytarabine + Venetoclax in de Novo AML

KIR Favorable Mismatched Haplo Transplant and KIR Polymorphism in ALL/AML/MDS Allo-HCT Children

A Prospective Randomized Comparison of HDAC Vs AD in the Induction Chemothrapy for AML.

Reduced Intensity Conditioning Regimens for Acute Myeloid Leukemia and Myelodysplastic Syndrome

CANSI

Multi-omics Approach of Risk Stratification for Patients With de Novo Acute Myeloid Leukemia